Nat West Group PLC Pfizer Inc Transaction History

Nat West Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $1.32 Million - $1.61 Million	-43,955 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $46,924 - $67,044	-1,736 Reduced 3.8%	43,955 $1.44 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $1.69 Million - $1.9 Million	45,691 New	45,691 $1.98 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $205,300 - $218,870	-6,225 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $106,432 - $112,928	-3,200 Reduced 33.95%	6,225 $225,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,425	9,425 $317,000

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

Stay updated on Nat West Group PLC with notifications on news.